25 March 2026
James Latham plc (“James Latham” or “the Company”) Trading Statement The Board of James Latham provides the following trading statement ahead of the Company’s…
Diageo subsidiary United Spirits Limited announces full divesture of its stake in Royal Challengers Sports Pvt Ltd Diageo plc subsidiary, United Spirits Limited (USL),…
Rio Tinto, Queensland and Commonwealth secure long-term future for Boyne aluminium smelter at Gladstone 25 March 2026 Rio Tinto, the Queensland Government and the…
YOUNG & CO.’S BREWERY, P.L.C. (“Young’s” or the “Company”) UPDATE ON MOVE TO THE MAIN MARKET Young’s, the premium operator of pubs and bedrooms…
24 March 2026
M.P. EVANS GROUP PLC FINAL RESULTS 2025 ANOTHER YEAR OF RECORD PROFITS AND INCREASING SHAREHOLDER RETURNS M.P. Evans Group PLC (“M.P. Evans”, “the Group”…
Fevertree Drinks plc FY25 Preliminary Results to 31 December 2025 Positive strategic progress during the year Comfortable with market expectations for 2026 Highlights £m…
23 March 2026
Trading Update March 2026 It is encouraging that the Group’s trading performance remains in line with expectations, as outlined in the October 2025 trading…
GSK’s B7-H3-targeted antibody-drug conjugate, risvutatug rezetecan, granted Orphan Drug Designation for small-cell lung cancer in Japan GSK plc (LSE/NYSE: GSK) today announced that risvutatug rezetecan…